Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Choates et.al., "It takes two: uptake of carrier screening among male reproductive partners" Prenatal Diagnosis, 2019; 1-6
Tsao et.al., "A novel high-throughput molecular counting method with single base-pair resolution enables accurate single-gene NIPT" Scientific Reports 9, 14382 (2019)
MENLO PARK, Calif., March 10, 2020 /PRNewswire/ -- BillionToOne, Inc., the precision diagnostics company that invented the patent-pending QCT™ molecular counter platform, announced today that it has closed its follow-on Series A+ funding round of $15 million with select global investors.
According to an independent peer-reviewed publication (Choates et al., 2020), less than half of male partners go through traditional carrier screening when indicated, limiting the identification of at-risk pregnancies.
Nipun Soni joined as our Chief Financial Officer in March 2021 and brings 20 years of finance, accounting and operations experience with multi-national companies in the Healthcare and Technology sector.
The Company has been growing its market share at an exponential pace, with test volumes increasing more than 300% year over year in the fiscal year 2021.
Doctor Palmer joined BillionToOne in March 2022 in a part-time capacity.
Rate how well BillionToOne lives up to its initial vision.
Do you work at BillionToOne?
Does BillionToOne communicate its history to new hires?
Zippia gives an in-depth look into the details of BillionToOne, including salaries, political affiliations, employee data, and more, in order to inform job seekers about BillionToOne. The employee data is based on information from people who have self-reported their past or current employments at BillionToOne. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by BillionToOne. The data presented on this page does not represent the view of BillionToOne and its employees or that of Zippia.
BillionToOne may also be known as or be related to BillionToOne, BillionToOne Inc., BillionToOne, Inc. and Billiontoone, Inc.